chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt stated day after he received vaccine his arm became sore,  still has not resolved. To the point he is having trouble putting on his jacket. No other reaction besides soreness- no redness, swelling, heat etc.  Pt states he asked his primary care provider about reaction and he did not seem too concerned. He then went to the chiropractor who used a TENS machine on his arm.  He did state that it has gotten an little better in the last few days, however he is concerned he is still having any reaction this far after the vaccine.
Client arrived for second dose of COVID vaccine and disclosed that she had a reaction to the first dose.  She described having "chest pain" two days later.  She denied of having experienced before and denied any cardiac history in the past.  She described the chest pain as pressure and she did "feel a lump in her throat."  This occurred after carrying groceries up stairs.  She denied doing anything out of the ordinary.  Denied difficulty breathing, swelling, or other symptoms. Client did not seek medical attention at the time.  Second dose was not administered.
pt recvd 3rd dose of vax 18NOV92 & 1 wk p/pt devel vitreous hemorrhage & had surgery 5DEC92 for detached retina;
Arm started getting hot and burning, then had a fever of 104F. The next morning, had pain in jaw and lower back-tightening up. Loss of appetite X 2 days. The fever lasted from 4/24/01 to 4/25/01 and then went down to 102F and the next day, it was 100F.
I have not been treated. I emailed with my doctor after dealing with this for the first two weeks. He stated it was most likely BPPV  Vertigo and provided instructions to do the canalith procedure at home.  I have done this procedure MANY times. I have an extremely busy work schedule and have not found an ENT in my medical plan to make an appointment with; just have been dealing with it. But from being a perfectly healthy 62, almost 63-year-old adult with no prior issues, no medications other than Warfarin for AT III Deficiency, this vertigo can be directly tied to my vaccinations.
I thought I had a sinus infection; I had been having allergy symptoms that had went away. I went to urgent care; they thought I had a bacterial sinus infection but also tested me for COVID-19 that came back positive. I was prescribed AUGMENTIN for the sinus infection and, PAXLOVID for the positive COVID-19. Since starting the PAXLOVID I have gotten laryngitis, my fever has been going up and down, I have fatigue.
Swelling at injection site (Pneumonia shot site), rash at injection site, arm soreness, joint pain, headache, neck pain, hip and lower back pain only low grade fever, sore throat.
Fever, seizure approximately 8 days after vaccines. Diagnosed with viral encephalitis at hospital. 12/03/09 Vac record received for DOS 11/22/09 12/22/09:  Provisional Autopsy report received for date of exam 10/9/09.  Findings:  Clinical history of seizures;  presented with status epilepticus and Influenza A (H1N1) positivity.  A.  Heavy lungs.  B.  Clinical hx. of encephalitis and brain herniation.  C. Other findings:  Heavy heart, pericardial effusion, hepatosplenomegaly.                    12/04/09 DC summary for DOS received for DOS 09/09/09  10/07/09. Final DX: Hypoxic ischemic encephalopathy  Pt presented with seizure, rigors, tonic-clinic seizures.  On neurological exam: febrile seizure, developed blown R pupil, diffuse cerebral edema, increased ICP; tx: hypertonic saline, pentobarbital, Tamiflu, Ativan, Dilantin, Manitol, serum sodium; Pt's condition worsened and Pt was not responsive. Physician related cerebral edema to H1N1 influenza related encephalitis or metabolic disorders. Pt expired on 10/07/09.
After the vaccine was completed, patient was sitting in the chair and complained of mild dizziness and feeling sweaty. I immediately placed an ice pack on his neck and elevated his legs along with  giving  him some cold Gatorade. He sat with his eyes closed and after 5-7 minutes the symptoms began to subside. After about 20-25 minutes he was able to stand without difficulty and was able to walk around.
Client received #1 Hep B vaccine on 7/30/04 sometime between 8:30am - 11am. Phone call from mother of client stating at about 11:30am developed hives and itchy rash all over. Advised on taking Benadryl (having some relief) and call Dr. Seen by Dr who advised not to continue with another vaccines of Hep B.
patch is hot to touch; knees are feeling hot in waves; left arm red swollen patch on the arm; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (patch is hot to touch), FEELING HOT (knees are feeling hot in waves), RASH (left arm red swollen patch on the arm) and FATIGUE (fatigue) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN WARM (patch is hot to touch), FEELING HOT (knees are feeling hot in waves), RASH (left arm red swollen patch on the arm) and FATIGUE (fatigue). At the time of the report, SKIN WARM (patch is hot to touch), FEELING HOT (knees are feeling hot in waves), RASH (left arm red swollen patch on the arm) and FATIGUE (fatigue) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided. No treatment information provided.
It was reported that a pt rec'd a TD adult vaccination on 4/25/00. Reportedly on 5/2/00, the pt developed a nodular density of the injection site with redness and swelling. Further information requested. From correspondence rec'd on 1/7/00, additional pt, vaccine and responsible physician information was provided.
Patient describes vaccine being given in the tricep area and a mound at the site at the time of administration.  Question whether this was given subcutaneously rather than intramuscularly.
Very red and swollen injection site reaction. Redness began to travel down arm into bicep area, Very sore to touch and move. Shoulder and elbow ROM = 100%.
Dermatomyositis/disease flared up in both skin and muscle; Dermatomyositis/disease flared up in both skin and muscle; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249 and expiration date not provided), via an unspecified route of administration, in right arm, on 11Feb2021 12:15 (at the age of 70-year-old, not pregnant), at single dose, for COVID-19 immunization. Medical history included dermatomyositis, IV contrast dye (Possibly IV contrast dye, minor itching). No COVID prior vaccination. Concomitant medication included prednisone. No other vaccine in four weeks. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date not provided), via an unspecified route of administration, in right arm, on 21Jan2021 (at the age of 70-year-old), at single dose, for COVID-19 immunization. Patient had dermatomyositis an autoimmune disease. 5 days after the second shot, on 16Feb2021, patient had disease flared up in both skin and muscle and had been prescribed prednisone 20 mg daily (6 weeks later). Prior to flare patient was stable on prednisone 5mg daily. Events resulted in doctor or other healthcare professional office/clinic visit. No COVID tested post vaccination. The outcome of the events was not recovered.
After i got the injection i was fine the entire day. After I went to bed, I had to go to the bathroom at 4 am. My arm was in pain, and as i got Tylenol I passed out. I fell and broke a rib. I passed out a second time when my husband tried to help me. I received a concussion. I saw my doctor the next day and issue my blood pressure, I never had  any issues with my blood pressure. It was a telamed visit, they didnt see me in person. I also had a seizure at the time.
Pain at injection site limiting mobility after about 6 hr, extreme chills with uncontrollable shaking  at about 12 hours and headache at about 18 hr.
I had severe abdominal pain  that changed at a day and a half to mild abdominal pain.
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 7 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient demographic details were not provided. The patient called to report that, 1 week after vaccination with Shingrix, the patient experienced shingles. The all above information was received at the time of reporting.
Dizziness; she felt that her arm "fell asleep", later began experiencing pain; Nausea; Vomiting all night long; Cannot raise arm; Sweating; Heat pangs; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Cannot raise arm), HYPERHIDROSIS (Sweating), FEELING HOT (Heat pangs), DIZZINESS (Dizziness) and MYALGIA (she felt that her arm "fell asleep", later began experiencing pain) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medication history was provided.     On 25-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced MOBILITY DECREASED (Cannot raise arm), HYPERHIDROSIS (Sweating), FEELING HOT (Heat pangs), MYALGIA (she felt that her arm "fell asleep", later began experiencing pain), NAUSEA (Nausea) and VOMITING (Vomiting all night long). On an unknown date, the patient experienced DIZZINESS (Dizziness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (Cannot raise arm), HYPERHIDROSIS (Sweating), FEELING HOT (Heat pangs), DIZZINESS (Dizziness), MYALGIA (she felt that her arm "fell asleep", later began experiencing pain), NAUSEA (Nausea) and VOMITING (Vomiting all night long) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medication use was unknown  Ice pack was also used  to resolve the symptoms.The reactions settled in about two days. The patient was fine now and scheduled to get  the 2nd dose in a few days.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 and Event outcome was updated.
rash across his chest and under his arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash across his chest and under his arms) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Aug-2021, the patient experienced RASH (rash across his chest and under his arms). At the time of the report, RASH (rash across his chest and under his arms) had resolved.            No concomitant medication were provided by the reporter.  Patient used cerave cream  as treatment medication for the rash and it worked.   This case was linked to MOD-2021-286916 (Patient Link).   Reporter did not allow further contact
first shot in 2018 can I get the second shot; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked, if could get 2nd shot.
Patient  said at time of injection experienced pain and has been having left arm pain for 1 month
an expired Pediarix was given; This case was reported by a nurse via sales rep and described the occurrence of expired vaccine used in a 3-month-old patient who received DTPa-HBV-IPV (Pediarix) (batch number unknown, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st December 2022, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 1st December 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-DEC-2022 and 02-DEC-2022 Reporter's Comment: The reporter called to report that, an expired dose of Pediarix had been administered to a patient. The Vaccine Administration Facility was the same as Primary Reporter. The reporter did not had any information on the patient (only the age) or the vaccine (dose, lot number, etc.) since the information was at the clinic. However, consent for follow-up by safety team was granted. The reporter had no information on the patient or any other details.  The reporter said that, follow-up via e-mail would be better than via phone number. Additional Supportive Information: The reporter reported that, an expired Pediarix was given to a patient (expired drug used),which led to expired vaccine used.
This is a spontaneous report initially reported from a contactable consumer. Follow-up information from a contactable nurse provided events that occurred after the fourth dose of PREVNAR 13. These events were initially thought to have occurred after a subsequent fifth dose given in error (see case report 201102879, medications error non-serious). This is the first of two reports. A 13-month-old male patient received the fourth dose of PREVNAR 13) on 24-Mar-2011 via intramuscular route for immunization. Additional relevant suspect vaccines administered on the same date include haemophilus influenzae b and hepatitis A vaccine for immunization. No relevant medical history or concomitant medication was reported. At the age of 14 months, on 22Apr2011, the mother reported the child experienced sickness (not specified). On 27Apr2011, the patient was diagnosed with bronchiolitis and conjunctivitis and was hospitalized (for little less than 24 hrs). The mother also mentioned that her son was cranky and had a cough for an unknown duration in APR2011 (exact date not provided). Therapeutic measures taken in response to the bronchiolitis included albuterol sulfate (dose and frequency unknown), ciprofloxacin eye drops for conjunctivitis (unknown duration in 2011, unknown dose four times a day), and MOTRIN (unknown duration, unknown dose as needed orally). (It was also reported that) the consumer was also put on oxygen hold for about four days after he was discharged from the hospital. The outcome of conjunctivitis was recovered on 01May2011. The outcome of bronchiolitis and cough was recovered on 6MAY2011. The outcome of cranky was not recovered at the time of this report. Follow-up attempts completed. No further information expected. Follow-up (01Jun2011): New information from a contactable nurse includes: clinical course details including vaccine details. Based on the information provided in the case, this individual report would not seem to modify the benefit/risk profile of PREVENAR 13.
I'm actually not sure if the Dtap was INFANRIX or the other- I don't have that information. About 24 hours after injection, the patient complained of pain when bending her leg, and hives were noticed later that evening. Her whole thigh was enlarged, hot, and tight to the touch. We went to Urgent Care and BENADRYL/monitoring was recommended. Swelling finally subsided by 3/22/2019 but discoloration remains.
Itching all over my body and scalp.  Light rashes here and there.  Taking Benadryl.  Dr. really didnt want to give me steroid meds because im diabetic but i have an appt with her tomorroe 1/26/21 11:15am
On 10/28/2021, 1 week after VX, participant started getting debilitating migraines and fatigue that didn't subside. Had to stop working on approximately 12/15/2021. Was admitted to the hospital from 12/28/2021 - 01/02/2022. In the hospital she was treated with an IV of DHE, Steroids and Toradol. Two days after hospital release, migraines started again. Was re-hospitalized on 2/22/2022 - 2/24/2022. Given DHE, Steroids and Botox. Released from hospital again and started having migraines that were milder. Her Dr. wants to switch her medication but she's waiting for her Insurance approval. Has also started suffering from depression as a result of these conditions.
Pt experienced chest pain/tightness three hours post vax that lasted for three to four hours.
Symptoms of temperature of 104, stiff neck, sore legs and arms, and photophobia. Taken to ER where physician did a spinal tap. Physician then decided the symptoms were a reaction to the vaccine the pt had received earlier in the day. Medical director recommended an antibody level for 9/11/00 and not to have pt receive the last vaccine.
This spontaneous report received from a medical assistant referred to an multiple unknown patients of unknown age and gender. It was reported that the multiple patients were vaccinated with (Oka/Merck) VARIVAX (Dose, frequency were not reported) (Lot numbers: L050956, Expiry date: 17-DEC-2017; lot L035126, Expiry date: 14-SEP-2017; lot L021214, expiry date: 10-JUN-2017, lot: L048468, Expiry date: 02-DEC-2017) which were improperly stored on multiple dates (incorrect product storage). The reported vaccine was stored at -13.1 degree C for 10 hours. No adverse effects reported. There was no previous excursion. This is one of the two reports received from the same reporter. Additional information was requested.
Patient presents to clinic for her second dose of the Covid 19 vaccine.  Pt had received the first dose of the Pfizer vaccine and was here to receive her second dose, patient was given Moderna as a second dose instead of the Pfizer needed.  No adverse reactions were noted and patient reported no symptoms.
09/27/21 The patient presents with chest pain and SOB starting around 01:30. After feeling uncomfortable with chest pressure symptomat all night, Pt called EMS and received 324mg ASA and nitro x1 en route. Pt states she is still having chest pressure but currently it is minimal. Pt states she was feeling fine yesterday and denies fever, cough, congestion, back pain, hematuria, and NVD. Pt has not had this feeling before. Pt notes that the pain is mostly on her left side and does not radiate.
27 year old female received age inappropriate Boostrix Tdap licensed for age 10-18.
Low-grade fever (99.5), aching joints (moderate), headache (mild-moderate).  All resolved within 36 hours of injection.  Sore arm (mild-moderate)
Acute onset severe left lower back pain, following gradually increasing intermittent low back pain over the previous year (or possibly two), evaluated in an emergency department, later in another emergency department and by my primary care physician.  Treated with NSAID, muscle relaxers, prednisone in sequence, later again with acupuncture, then NSAID and now physical therapy.  Symptoms improved, not totally resolved.  Still under evaluation and treatment.
Patient reported onset of a rash and hives over torso and back, onset on evening of first dose, lasting 4-5 days. Patient took benadryl to relieve itching. Patient arrived for second dose, and was advised to see allergist before returning for second dose.
Patient history of allergic reaction to 1st dose of vaccine. was advised by MD to get 2nd dose but must pre medicate with Benadryl. Patient complaint of slight tingling of throat that gradually progressed to lips. RRT Called. Patient went to ED.
admit for cough, sore throat, body aches, headache, n/v/d, O2 80% on RA prior to arrival, - COVID +. COVID Pneumonia, hypoxia, acute CHF. O2 @ 4L, dexamethasone, zinc, Vit C, remdisivir X5 days. O2 increased to 50L HF. VQ showed PE placed on heparin gtt. elevated troponin, chest pain - moved to ICU. no cath per cardiologist.  O2 up to 60L high -flow.  EF 35%.  NSTEMI. given toci. up to chair, sats 79-83 on 50L high flow and nonrebreather. pt does not want intubation. using BIPAP and alternating with 60L high flow/nonrebreather.  sating 70 % on 100% bipap. switched back to high FiO2 with high flow NC as well as nonrebreather. pt complained of chest pain, VTAC, coded. Code blue called, CPR started,  Intubatation, fami
PATIENT STATED SHE HAD PAIN IN THE ARM THE NIGHT OF THE VACCINATION. SHE STATED SHE NOW HAS A RED AND INFLAMED AREA ABOUT THE SIZE OF A SILVER DOLLAR. I INSTRUCTED HER TO APPLY ICE TO THE AREA 15 MINS ON AND 15 MINS OFF FOR A BIT TO SEE IF THIS HELPS.
Dylan suffered drop attacks in the three days that followed the vaccination. He then developed a fever of 103 F.  He was brought to an ER where he then suffered a seizure that was stopped after 15 minutes with a dose of adavan.
three different cancer at the same time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 52-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "a little vegan" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: NEOPLASM MALIGNANT (medically significant), outcome "unknown", described as "three different cancer at the same time". Patient never had cancer before. She thought she might have gotten exposed while travelling but her parents were there too and didn't get it (pending clarification). The reporter stated there were increases in all kinds of cancer and its from the injection. Patient didn't believe it but reporter knew it's from the vaccine. Patient was going to see oncologists.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Felt tiredfrom after vaccine, may have had a fever. Had a syncopal event 34 hours after vaccination